Latest disclosed trades
Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.
See the tradesUpdated Oct 17 · 2 feeds behind: Insider filings, 2 days, and 1 more · Every feed →
PTCT · sells only · 65 trades
Trades
65
Buys 0 · Sells 65
People
9
Stocks
1
Disclosed value
$23.7M
range midpoints · Congress & executive
Filed late
5
- ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$133Kdisclosed Aug 19 · filed 2 days after the trade
- ▼ SELLMatthew B. Klein Chief Executive OfficerPTCT Ptc Therapeutics, Inc.$706Kdisclosed Aug 6 · filed 2 days after the trade
- ▼ SELLPierre Gravier Chief Financial OfficerPTCT Ptc Therapeutics, Inc.$281Kdisclosed Jul 16 · filed 2 days after the trade
- ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$222Kdisclosed Jul 13 · filed 4 days after the trade
- ▼ SELLMary L. Smith DirectorPTCT Ptc Therapeutics, Inc.$900Kdisclosed Jul 13 · filed 4 days after the trade
- ▼ SELLMary L. Smith DirectorPTCT Ptc Therapeutics, Inc.$525Kdisclosed Jul 13 · filed 4 days after the trade
- ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$345Kdisclosed Jul 8 · filed 1 day after the trade
- ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$33.2Kdisclosed Jul 8 · filed 2 days after the trade
- ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$44.6Kdisclosed Jul 8 · filed 2 days after the trade
- ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$26Kdisclosed Jul 8 · filed 2 days after the trade
- ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$51.9Kdisclosed Jul 8 · filed 2 days after the trade
- ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$871Kdisclosed Jul 8 · filed 2 days after the trade
- ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$87.4Kdisclosed Jul 8 · filed 2 days after the trade
- ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$64.4Kdisclosed Jul 8 · filed 2 days after the trade
- ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$831Kdisclosed Jul 8 · filed 1 day after the trade
- ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$32.2Kdisclosed Jul 8 · filed 2 days after the trade
- ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$36.3Kdisclosed Jul 8 · filed 2 days after the trade
- ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$750Kdisclosed Jul 8 · filed 2 days after the trade
- ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$55.4Kdisclosed Jul 8 · filed 2 days after the trade
- ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$215Kdisclosed Jul 8 · filed 2 days after the trade
- ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$1Mdisclosed Jul 8 · filed 1 day after the trade
- ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$70.3Kdisclosed Jul 8 · filed 2 days after the trade
- ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$35.1Kdisclosed Jun 30 · filed 4 days after the trade
- ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$658Kdisclosed Jun 30 · filed 4 days after the trade
- ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$981Kdisclosed Jun 26 · filed 1 day after the trade